These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14224432)

  • 1. FIBRINOLYTIC ACTIVITY OF THE HAGEMAN FACTOR.
    AZNAR J; SANTIAGO E; MACARULLA JM
    Rev Esp Fisiol; 1964 Sep; 20():101-7. PubMed ID: 14224432
    [No Abstract]   [Full Text] [Related]  

  • 2. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FIBRINOLYTIC PROPERTIES OF THE CONTACT FACTOR].
    AZNAR J
    Rev Esp Fisiol; 1964 Jun; 20():43-51. PubMed ID: 14185256
    [No Abstract]   [Full Text] [Related]  

  • 4. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.
    IATRIDIS SG; FERGUSON JH
    J Clin Invest; 1962 Jun; 41(6):1277-87. PubMed ID: 14450472
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
    Herold R; Straub PW
    J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of the contact factor (Hageman factor) in fibrinolysis].
    NIEWIAROWSKI S; PROU-WARTELLE O
    Thromb Diath Haemorrh; 1959 Sep; 3():593-603. PubMed ID: 14427142
    [No Abstract]   [Full Text] [Related]  

  • 7. HAGEMAN FACTOR IN THE FIBRINOLYTIC SYSTEM.
    AZNAR J; LOPEZ-BORRASCA A
    Lancet; 1965 Feb; 1(7382):437-8. PubMed ID: 14238112
    [No Abstract]   [Full Text] [Related]  

  • 8. [Factor XII (HAGEMAN FACTOR)].
    Kase F; Klír P; Pospísil J; Poucková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic properties of the Hageman factor. (Thromboelastographical study)].
    AZNAR J; LOPEZ BORRASCA A; CALATAYUD R; BARATA JJ
    Rev Clin Esp; 1963 Jun; 89():276-81. PubMed ID: 13965764
    [No Abstract]   [Full Text] [Related]  

  • 10. Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation.
    Austen KF
    Transplant Proc; 1974 Mar; 6(1):39-45. PubMed ID: 4274038
    [No Abstract]   [Full Text] [Related]  

  • 11. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
    Kaplan AP
    Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
    Kaplan AP; Meier HL; Mandle RJ
    Monogr Allergy; 1977; 12():120-30. PubMed ID: 335210
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma inhibitors of the Hageman factor dependent pathways.
    Schreiber AD
    Semin Thromb Hemost; 1976 Jul; 3(1):32-51. PubMed ID: 799348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hageman factor and fibrinolysis.
    Holemans R; McConnell D; Johnston JG
    Am J Med Sci; 1966 May; 251(5):557-62. PubMed ID: 5933769
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of activated Hageman factor on the blood coagulation system in vivo].
    Ashkinazi IIa; Klemina IK
    Biull Eksp Biol Med; 1970 Apr; 69(4):32-6. PubMed ID: 5487897
    [No Abstract]   [Full Text] [Related]  

  • 16. The "Hageman" connection: interrelationships of blood coagulation, fibrinogenolysis, kinin generation, and complement activation.
    Murano G
    Przegl Lek; 1981; 38(10):709-13. PubMed ID: 7330256
    [No Abstract]   [Full Text] [Related]  

  • 17. Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarction.
    Kluft C; Munkvad S; Gram J; Jespersen J
    Agents Actions Suppl; 1992; 38 ( Pt 2)():299-304. PubMed ID: 1462835
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THROMBOLYSIS: DIRECT DETERMINATION OF FIBRINOLYTIC SUBSTANCES BY MEANS OF STATIC RETRACTROMETRY].
    SCHULTE W
    Thromb Diath Haemorrh; 1964 Oct; 12():282-94. PubMed ID: 14224639
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenochrome semicarbazone and lack of in vivo activation of Hageman factor.
    White NB; Iatridis PG; Ferguson JH
    Am J Med Sci; 1966 Jun; 251(6):668-73. PubMed ID: 5946367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.